{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:10:07Z","timestamp":1760062207293,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002224","name":"Melanoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejso.2019.02.026","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T21:44:09Z","timestamp":1551217449000},"page":"832-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study"],"prefix":"10.1016","volume":"45","author":[{"given":"Hidde M.","family":"Kroon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendon J.","family":"Coventry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Serpell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Mark","family":"Smithers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2019.02.026_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jso.22029","article-title":"Local and intralesional therapy of in-transit melanoma metastases","volume":"104","author":"Testori","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1245\/s10434-015-4969-2","article-title":"Australian multi-center study of isolated limb infusion for melanoma","volume":"23","author":"Kroon","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jamcollsurg.2008.12.019","article-title":"A\u00a0multi-institutional experience of isolated limb infusion: defining response and toxicity in the US","volume":"208","author":"Beasley","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2019.02.026_bib4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jso.23553","article-title":"Isolated limb infusion with melphalan and actinomycin D for melanoma: a systematic review","volume":"109","author":"Kroon","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib5","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.14694\/EdBook_AM.2015.35.e528","article-title":"Perfusion and infusion for melanoma in-transit metastases in the era of effective systemic therapy","volume":"35","author":"Gr\u00fcnhagen","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejso.2019.02.026_bib6","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1245\/s10434-016-5150-2","article-title":"Clinical response and regional toxicity following isolated limb infusion compared with isolated limb perfusion for in-transit melanoma","volume":"23","author":"Dossett","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib7","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1002\/cncr.27676","article-title":"A\u00a0multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion","volume":"118","author":"Beasley","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2019.02.026_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1245\/s10434-012-2782-8","article-title":"Isolated limb infusion in a series of over 100 infusions: a single-center experience","volume":"20","author":"Wong","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/000313481207800718","article-title":"Clinicopathologic and survival differences between upper and lower extremity melanomas","volume":"78","author":"Egger","year":"2012","journal-title":"Am Surg"},{"key":"10.1016\/j.ejso.2019.02.026_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1440-1584.2008.00987.x","article-title":"Geographical variation of incidence of cutaneous melanoma in Queensland","volume":"16","author":"Buettner","year":"2008","journal-title":"Aust J Rural Health"},{"key":"10.1016\/j.ejso.2019.02.026_bib11","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib12","series-title":"Textbook of melanoma","first-page":"429","article-title":"Isolated limb infusion for melanoma","author":"Thompson","year":"2004"},{"key":"10.1016\/j.ejso.2019.02.026_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jso.23540","article-title":"Isolated limb infusion: technical aspects","volume":"109","author":"Kroon","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib14","first-page":"243","article-title":"Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit","volume":"5","author":"Giles","year":"2013","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejso.2019.02.026_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib16","first-page":"36","article-title":"The value of monitoring serum creatine phosphokinase values following hyperthermic isolated limb perfusion for melanoma","volume":"6","author":"Lai","year":"1993","journal-title":"Reg Cancer Treat"},{"year":"1979","series-title":"WHO handbook for reporting results of cancer treatments. WHO Offset Publication No. 48","author":"World Health Organization","key":"10.1016\/j.ejso.2019.02.026_bib17"},{"key":"10.1016\/j.ejso.2019.02.026_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1985","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.ejso.2019.02.026_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1245\/s10434-011-2030-7","article-title":"20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters","volume":"19","author":"Deroose","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib20","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1245\/s10434-010-1104-2","article-title":"Long-term results of melphalan based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases","volume":"17","author":"Rossi","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib21","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1245\/s10434-008-9954-6","article-title":"Outcomes following isolated limb infusion for melanoma: a 14-year experience","volume":"15","author":"Kroon","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cncr.24736","article-title":"Isolated limb infusion with cytotoxic agents: a simplified approach for venous access","volume":"116","author":"Vyas","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2019.02.026_bib23","first-page":"6","article-title":"Pelvic stop flow infusion (PSI) and hypoxic pelvic perfusion (HPP) with mitomycin and melphalan for recurrent rectal cancer","volume":"1","author":"Aigner","year":"1994","journal-title":"Reg Cancer Treat"},{"key":"10.1016\/j.ejso.2019.02.026_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0360-3016(91)90106-E","article-title":"Effects of oxygenation and pH on tumor cell response to alkylating chemotherapy","volume":"20","author":"Siemann","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2019.02.026_bib25","first-page":"219","article-title":"The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake","volume":"15","author":"Skarsgard","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2019.02.026_bib26","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1245\/s10434-013-3222-0","article-title":"Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma","volume":"21","author":"Speicher","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib27","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1245\/s10434-009-0323-x","article-title":"Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin-D in melanoma patients","volume":"16","author":"Kroon","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/bjc.1994.266","article-title":"Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb","volume":"70","author":"Klaase","year":"1994","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2019.02.026_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/BF02384984","article-title":"Technique and results of regional hyperthermic cytostatic arm perfusion for malignant melanoma","volume":"27","author":"W\u00fcrl","year":"1997","journal-title":"Surg Today"},{"key":"10.1016\/j.ejso.2019.02.026_bib30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1245\/s10434-014-4072-0","article-title":"Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin d in melanoma","volume":"22","author":"Muilenburg","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib31","first-page":"30","article-title":"New does not always mean better: isolated limb perfusion still has a role in the management of in-transit melanoma metastases","volume":"15","author":"Puzanov","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.ejso.2019.02.026_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2019.02.026_bib33","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1200\/JCO.2010.32.1224","article-title":"Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma","volume":"29","author":"Beasley","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib34","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1245\/s10434-012-2373-8","article-title":"A\u00a0phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity","volume":"19","author":"Beasley","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.026_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/2326-6066.CIR-17-0356","article-title":"Robust antitumor responses result from local chemotherapy and CTLA-4 blockade","volume":"6","author":"Ariyan","year":"2018","journal-title":"Cancer Immunol Res"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319302999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319302999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:29:50Z","timestamp":1760059790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319302999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0748798319302999"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.02.026","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}